Astellas Venture Management LLC. Site Map
 
Home > Portfolio
 
Portfolio

 AVF I

AVC

FITE/FITE II

DecImmune Therapeutics, Inc.
Boston, MA, USA

Cellzome AG
Heidelberg, Germany

Alba Therapeutics
Baltimore, MD, USA  

EpiZyme, Inc.
Cambridge, MA, USA

Evolva SA
Allschwill, Switzerland

FASgen
Baltimore, MD, USA

F2G, Ltd.
Manchester, UK

CoMentis, Inc.
So. San Francisco, CA, USA

Linden Bioscience
Woburn, MA, USA

Fate Therapeutics, Inc.
San Diego, CA, USA

Plexxikon, Inc.
Berkely, CA, USA

Neuronautics, Inc.
Highland Park, IL, USA

Inimex Pharmaceuticals, Inc.
Burnaby, BC, Canada

 

PhysioGenix, Inc.
Wauwatosa, WI, USA

Lectus Therapeutics Ltd.
Cambridge, UK

Renovar Incorporated
Madison, WI, USA

Nereus Pharmaceuticals, Inc.
San Diego, CA, USA

 

Revivicor, Inc.
Blacksburg, VA, USA

Viamet Pharmaceuticals, Inc.
Morrisville, NC, USA

 

 


Portfolio Exits

 AVF I

AVC

FITE/FITE II

Intradigm Corporation
Palo Alto, CA, USA

AkaRx, Inc.
Paramus, NJ, USA

Adhelex Technologies
Ottawa, Canada

EPIX Pharmaceuticals
Cambridge, MA, USA

Ception Therapeutics
Rockville, MD, USA

 

Memory Pharmaceuticals
Montvale, NJ, USA

Cytomyx Holdings PLC
Cambridge, UK

 

 

Prolysis Limited
Oxfordshire, UK

 
Copyright © 2005 - 2010 Astellas Venture Mangement. Site Map  Privacy Policy  Legal Disclaimer  Contact Us